Harnessing the power of clustered regularly interspaced short palindromic repeats (CRISPR) based microfluidics for next-generation molecular diagnostics
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09840-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Rasanpreet Kaur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Institute of Applied Sciences & Humanities, GLA University, Chaumuhan, 281406, Mathura, Uttar Pradesh, India. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Microfluidics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 156 Literaturangaben.
Abstract (Originalsprache)
CRISPR-based (Clustered regularly interspaced short palindromic repeats-based) technologies have revolutionized molecular biology and diagnostics, offering unprecedented precision and versatility. However, challenges remain, such as high costs, demanding technical expertise, and limited quantification capabilities. To overcome these limitations, innovative microfluidic platforms are emerging as powerful tools for enhancing CRISPR diagnostics. This review explores the exciting intersection of CRISPR and microfluidics, highlighting their potential to revolutionize healthcare diagnostics. By integrating CRISPR's specificity with microfluidics' miniaturization and automation, researchers are developing more sensitive and portable diagnostic tools for a range of diseases. These microfluidic devices streamline sample processing, improve diagnostic performance, and enable point-of-care applications, allowing for rapid and accurate detection of pathogens, genetic disorders, and other health conditions. The review discusses various CRISPR/Cas systems, including Cas9, Cas12, and Cas13, and their integration with microfluidic platforms. It also examines the advantages and limitations of these systems, highlighting their potential for detecting DNA and RNA biomarkers. The review also explores the key challenges in developing and implementing CRISPR-driven microfluidic diagnostics, such as ensuring robustness, minimizing cross-contamination, and achieving robust quantification. Finally, it highlights potential future directions for this rapidly evolving field, emphasizing the transformative potential of these technologies for personalized medicine and global health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Institute of Applied Sciences & Humanities, GLA University, Chaumuhan, 281406, Mathura, Uttar Pradesh, India.
- Department of Biotechnology, Institute of Applied Sciences & Humanities, GLA University, Chaumuhan, 281406, Mathura, Uttar Pradesh, India. saurabh.gupta@gla.ac.in.
- Department of Biotechnology, Dr. Rammanohar Lohia Avadh University, Ayodhya, 224001, Uttar Pradesh, India.
- Department of Translational Medicine, All India Institute of Medical Sciences Bhopal, Saket Nagar, Bhopal, 462020, Madhya Pradesh, India.
Zitieren
APA
Kaur, R., Gupta, S., Chauhan, A., Mishra, V., Sharma, M. K., & Singh, J. (2024). Harnessing the power of clustered regularly interspaced short palindromic repeats (CRISPR) based microfluidics for next-generation molecular diagnostics. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09840-8
Vancouver
Kaur R, Gupta S, Chauhan A, Mishra V, Sharma MK, Singh J. Harnessing the power of clustered regularly interspaced short palindromic repeats (CRISPR) based microfluidics for next-generation molecular diagnostics. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09840-8
BibTeX
@article{Kaur2024,
author = {Kaur, Rasanpreet and Gupta, Saurabh and Chauhan, Arjun and Mishra, Vidhi and Sharma, Manish Kumar and Singh, Jitendra},
title = {Harnessing the power of clustered regularly interspaced short palindromic repeats (CRISPR) based microfluidics for next-generation molecular diagnostics},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09840-8}
}
EUVIMED